Vincent Emond

Quebec, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

High molecular weight insoluble parkin in the substantia nigra of patients with idiopathic Parkinson's disease.

High molecular weight insoluble parkin in the substantia nigra of patients with idiopathic Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: November 12, 2025

Regional heterogeneity of the blood-brain barrier.

Regional heterogeneity of the blood-brain barrier.

Journal: Nature communications

Published: March 14, 2025

Differential impact of eicosapentaenoic acid and docosahexaenoic acid in an animal model of Alzheimer's disease.

Differential impact of eicosapentaenoic acid and docosahexaenoic acid in an animal model of Alzheimer's disease.

Journal: Journal of lipid research

Published: June 24, 2024

Correction to: Higher angiotensin‑converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's disease.

Correction to: Higher angiotensin‑converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's disease.

Journal: Acta neuropathologica communications

Published: November 02, 2023

Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's disease.

Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's disease.

Journal: Acta neuropathologica communications

Published: August 29, 2023

Additive neurorestorative effects of exercise and docosahexaenoic acid intake in a mouse model of Parkinson's disease.

Additive neurorestorative effects of exercise and docosahexaenoic acid intake in a mouse model of Parkinson's disease.

Journal: Neural regeneration research

Published: April 13, 2023

Pharmacokinetics, biodistribution and toxicology of novel cell-penetrating peptides.

Pharmacokinetics, biodistribution and toxicology of novel cell-penetrating peptides.

Journal: Scientific reports

Published: December 20, 2022

Postsynaptic Protein Shank3a Deficiency Synergizes with Alzheimer's Disease Neuropathology to Impair Cognitive Performance in the 3xTg-AD Murine Model.

Postsynaptic Protein Shank3a Deficiency Synergizes with Alzheimer's Disease Neuropathology to Impair Cognitive Performance in the 3xTg-AD Murine Model.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: August 09, 2022

Cerebrovascular insulin receptors are defective in Alzheimer's disease.

Cerebrovascular insulin receptors are defective in Alzheimer's disease.

Journal: Brain : a journal of neurology

Published: March 31, 2022

Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons.

Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons.

Journal: Scientific reports

Published: January 27, 2022

Sex-dependent alterations in the physiology of entorhinal cortex neurons in old heterozygous 3xTg-AD mice.

Sex-dependent alterations in the physiology of entorhinal cortex neurons in old heterozygous 3xTg-AD mice.

Journal: Biology of sex differences

Published: July 17, 2020

Dietary intake of branched-chain amino acids in a mouse model of Alzheimer's disease: Effects on survival, behavior, and neuropathology.

Dietary intake of branched-chain amino acids in a mouse model of Alzheimer's disease: Effects on survival, behavior, and neuropathology.

Journal: Alzheimer's & dementia (New York, N. Y.)

Published: December 19, 2018

Showing 1-12 of 21

Last Updated: 09/26/2026